PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2007 2008 2009
This is a new activity in FY08.
In FY07, the Supply Chain Management System (SCMS) provided a small amount of technical assistance
(TA) for OI drug procurement and distribution. This cost was covered under the funding to SMCS for ARV
Services. However, this year the amount of OI drugs is substantially increasing, and thus the TA cost is
substantially increasing. We are producing a separate activity narrative, with a separate budget, for this
activity in FY08.
SCMS will support the PEPFAR Vietnam 5-year strategy to provide palliative care to PLWHA, through the
provision of OI medications and procurement and distribution of methadone. SCMS will support the
following objectives in the procurement of OI drugs and methadone by the government of Vietnam (GVN)
(see Palliative Care Basic section): 1) Capacity building by enhancing the ability of governmental,
specifically the new Ministry of Health/Vietnam Administration for HIV/AIDS Control (MOH/VAAC) drug
management unit, international and local partners to systematically identify, prioritize and address
pharmaceutical management issues to improve access to and use of quality OI drugs and methadone; 2)
SCMS will also strengthen the pharmaceutical management of health facilities to ensure an uninterrupted
supply of quality pharmaceuticals to treat opportunistic infections and drug dependence; 3) Provide
technical assistance to VAAC and Ho Chi Minh City Provincial AIDS Committee (HCMC PAC) to monitor
and evaluate procurement, distribution and storage of OI drugs through collection of site-level data, and
development of quarterly reports that inform all partners about use of OI drugs, situation at clinical sites in
terms of drug supplies, actual use of clinical protocols and projections of future patients to allow strategic
planning for the government in terms of drug supplies and future procurement.
Specifically SCMS will: 1) Provide TA to enhance decision-making at the VAAC and HCMC PAC for
pharmaceutical and commodity management such as in-country forecasting and drug management and
play a coordinating role with partners' organization on pharmaceutical issues; 2) Work with the PEPFAR
care and treatment technical working group to provide TA to GVN partners to develop an approved list of OI
drugs to be procured and oversee and manage procurement, importation, storage, distribution and supply of
quality OI drugs and develop a distribution plan for implementation sites; 3) Closely collaborate and support
the VAAC pharmacy unit to build capacity and move towards coordination of procurement and distribution of
all OI drugs; 4) Strengthen drug management information systems to provide timely accurate information
regarding procurement, distribution, and use of OI drugs and methadone supplied by all partners; 5)
Develop and implement standard operating procedures (SOPs) at appropriate levels, train and supervise
their effective implementation; 6) Train pharmacy personnel on commodity management of HIV medicines,
methadone and commodities; 7) Provide TA to GVN to develop a monitoring and evaluation system based
at the site level in support of the national drug management monitoring and evaluation plan; and 8) Assist
GVN to disseminate information about drug management to partner organizations and implementation sites,
and share lessons learned with the broader community.
This is a continuing activity from FY07. Early funding is requested.
The Supply Chain Management System (SCMS) will support the following three objectives described in the
program narrative: 1) capacity building by enhancing the ability of governmental, specifically the new
Ministry of Health/Vietnam Administration for HIV/AIDS Control (MOH/VAAC) drug management unit,
international and local partners to systematically identify, prioritize and address pharmaceutical
management issues to improve access to and use of quality ARVs supported by the national treatment
guidelines. SCMS also strengthens the pharmaceutical and laboratory management capacity of referral,
provincial, district, and other facilities to ensure an uninterrupted supply of quality HIV/ AIDS pharmaceutical
and other commodities at ART service delivery sites; and 2) procurement and distribution of ARVs, on
behalf of all USG civilian and Department of Defense ART implementation sites to support 22,000 patients
by September 2009. All pediatrics formulations will be provided in coordination with the Clinton HIV/AIDS
Initiative (CHAI) which will be purchasing the entire supply for Vietnam, while SCMS will pay the
importation, storage and distribution costs for all sites, both PEPFAR and non-PEPFAR; and 3) information
sharing, as part of monitoring and evaluation functions, through collection of site-level data, and
development of monthly reports that inform all partners about uptake of ARV patients, the situation at
clinical sites in terms of drug supplies, actual use of clinical protocols, projections of future patients, and
international trends in ARV medicines which allow strategic planning for the PEPFAR team in terms of drug
supplies and future expansion for the PEPFAR program.
Specifically SCMS will: 1) provide technical assistance (TA) to enhance decision-making at VAAC, other
central agencies, and donors for HIV/AIDS-related pharmaceutical and commodity management such as in-
country forecasting and drug management, and play a coordinating role with partners' organizations on
pharmaceutical issues; 2) provide TA to partners and sites to clarify the implications of changes in treatment
guidelines, various funding scenarios, and changes in the market; manage procurement, importation,
storage, distribution and supply of quality ARVs, consistent with USAID procurement guidelines, based on
available funding, and develop a distribution plan for implementation sites; 3) closely collaborate and
support the VAAC pharmacy unit to build capacity and move towards coordination of procurement and
distribution of all ARVs; 4) strengthen drug management information systems to provide timely accurate
information regarding procurement, distribution, and use of ARVs supplied by all partners; 5) develop and
implement standard operating procedures (SOPs) at appropriate levels, and train and supervise their
effective implementation; 6) train pharmacy personnel on commodity management of ARVs and related
medicines and commodities; 7) operate a monitoring and evaluation (M&E) system based at the site level in
support of the national drug management M&E plan in close coordination with the PEPFAR SI technical
working group (TWG); and 8) disseminate information about ARV drug management to partner
organizations and implementation sites, and share lessons learned with the broader community.
The Supply Chain Management System (SCMS) will support the PEPFAR Vietnam 5-year strategy to
provide 22,000 persons with ART. SCMS will support the following three objectives: 1) capacity building by
enhancing the ability of governmental, specifically the new Ministry of Health/Vietnam Administration of
HIV/AIDS Control (MOH/VAAC) drug management unit, international and local partners to systematically
identify, prioritize and address pharmaceutical management issues to improve access to and use of quality
ARVs supported by the national treatment guidelines. SCMS will also strengthen the pharmaceutical and
laboratory management capacity of other health facilities to ensure an uninterrupted supply of
pharmaceutical and other commodities at ART service delivery sites; 2) procurement and distribution of
ARVs, on behalf of all USG civilian and Department of Defense ART implementation sites to support 22,000
patients by September 2009. All pediatric formulations will be provided in coordination with the Clinton
Foundation who will be purchasing the entire supply for Vietnam, while SCMS will pay the importation,
storage and distribution costs for all sites, both PEPFAR and non-PEPFAR; and 3) information sharing, as
part of monitoring and evaluation functions, through collection of site-level data, and development of
monthly reports that inform all partners about uptake of ARV patients, situation at clinical sites in terms of
drug supplies, actual use of clinical protocols, projections of future patients, and inform partners of
Specific activities supported by these funds will include: 1) ongoing provision of pharmaceutical site
readiness at new and continuing PEPFAR-supported sites through training of pharmacy staff, site
monitoring, and on-going quality assurance (QA) and supportive supervision. SCMS will directly train 200
pharmacy staff at clinical sites; 2) SCMS will develop new standard operating procedures (SOPs), and
implement existing SOPs developed in previous years with PEPFAR funding, at the site level for
dispensers, at the pharmaceutical storage (CPC#1) warehouse, and at the ministry level; 3) SCMS will also
develop a pre-service training program in collaboration with Ho Chi Minh City School of Pharmacy. By
training the students in HIV/AIDS, medications related to treatment of HIV/AIDS and modern dispensing
practices, SCMS will help ensure that there are on-going human resources to support HIV treatment
programs in Vietnam. At the HCMC School of Pharmacy 100 pharmacy students will be trained; 4) SCMS
will also support procurement, management and distribution of CD4 reagents and laboratory supplies, which
will include visits to treatment sites, training of laboratory specialists at sites in commodity management,
and participation in a team of laboratory specialists within PEPFAR Vietnam. ARV service funding will go to
support procurement of CD4 reagents for FACS count machines for non-military ART sites, in accordance
with Vietnamese National Standard treatment guidelines and USAID procurement regulations. DOD will
procure CD4 reagents for military sites though a separate mechanism.
The Supply Chain Management System (SCMS) will support provincial and district antiretroviral service
delivery sites by ensuring the sites are provided with uninterrupted supplies of quality laboratory equipment,
reagents, and the materials that are necessary to diagnose diseases related to HIV/AIDS. While many of
these items are readily available domestically, materials needed to conduct molecular diagnostic tests must
be purchased on the international market. However, neither SCMS, nor Vietnam's Ministry of Health, have
permission to engage in import activities. SCMS will therefore have to use local vendors, who have the
proper import licenses, to procure the needed items. In order to avoid potential supply interruptions, these
funds will be used to cover any additional charges levied by third-party vendors.